Drug Name: Zilbrysq
Active Ingredient: zilucoplan
Indication: To treat moderately to severely active ulcerative colitis in adults
Approval Date: 10/17/2023
Company: UCB, Inc.
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf